Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amar Ajmal

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Pharmaceutical Design|May 7, 2022
Strategies for Targeting KRAS: A Challenging Drug TargetAbdul Wadood, Amar Ajmal, Ashfaq Ur Rehman
Genomics|June 21, 2020
Core proteome mediated therapeutic target mining and multi-epitope vaccine design for Helicobacter pyloriNoor Rahman, Amar Ajmal, Fawad Ali, et al.
Journal of Biomolecular Structure & Dynamics|October 27, 2022
Identification of novel peptide inhibitors for the KRas-G12C variant to prevent oncogenic signalingAmar Ajmal, Yasir Ali, Ajmal Khan, et al.
Heliyon|July 14, 2023
New drug target identification in <i>Vibrio vulnificus</i> by subtractive genome analysis and their inhibitors through molecular docking and molecular dynamics simulationsBader S Alotaibi, Amar Ajmal, Mohammed Ageeli Hakami, et al.
International Journal of Biological Macromolecules|June 4, 2024
Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulationsAbdul Nasir, Abdus Samad, Amar Ajmal, et al.
Journal of Biomolecular Structure & Dynamics|July 12, 2023
Structural and dynamics insights into the GBA variants associated with Parkinson's diseaseArif Mahmood, Abdus Samad, Shazia Bano, et al.
Current Pharmaceutical Design|August 1, 2022
Machine Learning-based Virtual Screening for STAT3 Anticancer Drug TargetAbdul Wadood, Amar Ajmal, Muhammad Junaid, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Identification of Drug Targets and Their Inhibitors in <i>Yersinia pestis</i> Strain 91001 through Subtractive Genomics, Machine Learning, and MD Simulation ApproachesHamid Ali, Abdus Samad, Amar Ajmal, et al.
Scientific Reports|June 7, 2024
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infectionsAmar Ajmal, Muhammad Shahab, Muhammad Waqas, et al.
RSC Advances|August 31, 2023
Novel flurbiprofen clubbed oxadiazole derivatives as potential urease inhibitors and their molecular docking studySajjad Ahmad, Momin Khan, Aftab Alam, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|May 7, 2022
Strategies for Targeting KRAS: A Challenging Drug TargetAbdul Wadood, Amar Ajmal, Ashfaq Ur Rehman
Genomics|June 21, 2020
Core proteome mediated therapeutic target mining and multi-epitope vaccine design for Helicobacter pyloriNoor Rahman, Amar Ajmal, Fawad Ali, et al.
Journal of Biomolecular Structure & Dynamics|October 27, 2022
Identification of novel peptide inhibitors for the KRas-G12C variant to prevent oncogenic signalingAmar Ajmal, Yasir Ali, Ajmal Khan, et al.
Heliyon|July 14, 2023
New drug target identification in <i>Vibrio vulnificus</i> by subtractive genome analysis and their inhibitors through molecular docking and molecular dynamics simulationsBader S Alotaibi, Amar Ajmal, Mohammed Ageeli Hakami, et al.
International Journal of Biological Macromolecules|June 4, 2024
Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulationsAbdul Nasir, Abdus Samad, Amar Ajmal, et al.
Journal of Biomolecular Structure & Dynamics|July 12, 2023
Structural and dynamics insights into the GBA variants associated with Parkinson's diseaseArif Mahmood, Abdus Samad, Shazia Bano, et al.
Current Pharmaceutical Design|August 1, 2022
Machine Learning-based Virtual Screening for STAT3 Anticancer Drug TargetAbdul Wadood, Amar Ajmal, Muhammad Junaid, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2023
Identification of Drug Targets and Their Inhibitors in <i>Yersinia pestis</i> Strain 91001 through Subtractive Genomics, Machine Learning, and MD Simulation ApproachesHamid Ali, Abdus Samad, Amar Ajmal, et al.
Scientific Reports|June 7, 2024
In silico design of peptide inhibitors for Dengue virus to treat Dengue virus-associated infectionsAmar Ajmal, Muhammad Shahab, Muhammad Waqas, et al.
RSC Advances|August 31, 2023
Novel flurbiprofen clubbed oxadiazole derivatives as potential urease inhibitors and their molecular docking studySajjad Ahmad, Momin Khan, Aftab Alam, et al.
Pageof 2